490 Biotech > Products
Detection: Androgen disruptor compounds
490 BioTech’s S. cerevisiae BLYAS strain is specially engineered to initiate autobioluminescent production upon exposure to androgen disruptor compounds. S. cerevisiae BLYAS expresses a human androgen receptor for ultra-low background detection of androgen disruptor compounds and autonomously self-modulates its resulting autobioluminescent reporter signal to provide positive compound identification in real time without the need for sample destruction or chemical treatment.
All prices are valid for academic, government, and non-commercial research customers. For commercial research or technology licensing applications, please contact 490 BioTech to obtain a quote and/or commercial research license.